United States Government Publishing Office publisher pbl distributor dst United States Congress House of Representatives author aut Government Organization text government publication eng CRPT Congressional Committee Materials 117_cong_reports legislative 2021-10-21 U.S. Government Publishing Office 2021-10-19 monographic deposited born digital 16 digital object pages Y 1.1/8:117-151 https://www.govinfo.gov/app/details/CRPT-117hrpt151 P0b002ee1b17aabc4 001165964 f:hr151.117.txt DGPO 2021-10-21 2024-11-08 CRPT-117hrpt151 machine generated eng fdlp Report to accompany H.R. 4369 HRPT CRPT-117hrpt151 HOUSE 117 151 1 false true https://www.govinfo.gov/app/details/CRPT-117hrpt151 https://www.govinfo.gov/content/pkg/CRPT-117hrpt151/html/CRPT-117hrpt151.htm https://www.govinfo.gov/content/pkg/CRPT-117hrpt151/pdf/CRPT-117hrpt151.pdf H. Rept. 117-151 The Committee on Energy and Commerce, to whom was referred the bill (H.R. 4369) to amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes, having considered the same, reports favorably thereon with amendments and recommends that the bill as amended do pass. NATIONAL CENTERS OF EXCELLENCE IN ADVANCED AND CONTINUOUS PHARMACEUTICAL MANUFACTURING ACT OF 2021;H. Rept. 117-151 Committed to the Committee of the Whole House on the State of the Union and ordered to be printed FIRSTPART CRPT-117hrpt151 Committed to the Committee of the Whole House on the State of the Union and ordered to be printed 1 21st Century Cures Act National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021 The Committee on Energy and Commerce, to whom was referred the bill (H.R. 4369) to amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes, having considered the same, reports favorably thereon with amendments and recommends that the bill as amended do pass. Mr. Pallone, from the Committee on Energy and Commerce, submitted the following Committee on Energy and Commerce Energy and Commerce Mr. Pallone Frank Pallone, Jr. Pallone, Frank Mr. Frank Pallone Jr.

H.R. 4369, 117th Frank Pallone, Jr. United States House of Representatives sponsor spn United States Congress Member United States Congress House of Representatives Committee on Energy and Commerce associated name asn Government Organization H.R. 4369 117 OTHER H.R. 4369 117 PRIMARY Title 20 Section 1001(a) 20 U.S.C. 1001(a) Title 21 Section 321 Title 21 Section 399h 21 U.S.C. 321 21 U.S.C. 399h Title 42 Section 262(i) 42 U.S.C. 262(i) Public Law 111-139 Public Law No 111-139 Public Law 114-255 Public Law No 114-255